Managing marketed health product-related side effects depends on healthcare professionals and consumers reporting them. Any adverse event or other serious or unexpected side effects to BCR-ABL TKIs should be reported to the appropriate manufacturer (see “Products affected”) or to Health Canada.
Novartis Pharmaceuticals Canada Inc.
385 Bouchard Blvd.
Dorval, Québec, H9S 1A9
1-800-363-8883
www.novartis.ca/en/util/contact/product.shtml
Pfizer Canada Inc. Canada
17 300 Trans-Canada Highway
Kirkland, Québec, H9J 2M5
1-800-463-6001
Bristol-Myers Squibb
2344, boul Alfred-Nobel, suite 300
Saint-Laurent, Quebec, H4S 0A4
1-866-463-6267
Email:
Safety_Canada@bms.com ARIAD Pharmaceuticals, Inc.
c/o Paladin Labs Inc.
100 Blvd Alexis-Nihon, Suite 600
Saint-Laurent, Quebec, H4M 2P2
1-888-867-7426
Email :
Medinfo@paladinlabs.com You can report any suspected adverse reactions associated with the use of health products to Health Canada by:
-
Calling toll-free at 1-866-234-2345; or
-
Visiting MedEffect Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.
For other health product inquiries related to this communication, contact Health Canada at:
Marketed Health Products Directorate
E-mail:
mhpd_dpsc@hc-sc.gc.ca
Telephone: 613-954-6522
Fax: 613-952-7738
Original signed by Aamir Shamim Choudry, MD, MBA.
Ad-Interim Chief
Scientific Officer
Novartis Pharmaceuticals Canada Inc.
Vratislav Hadrava M.D., Ph.D.
Vice-President and Medical Director
Pfizer Canada Inc.
Babak Abbaszadeh, MD, MBA
Vice President, Medical Affairs
Bristol-Myers Squibb Canada
Jean De Serres MD, M.Sc, MBA
Vice-President Scientific Affairs and Operations
Paladin Labs Inc.